Skip to content

Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer

Impact of Mechanism Based Acupuncture Intervention to Improve Weight Loss in GI Cancer Patients With Cachexia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02148159
Enrollment
45
Registered
2014-05-28
Start date
2014-10-31
Completion date
2016-05-31
Last updated
2019-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of Gastrointestinal Tract

Keywords

anorexia, cachexia, cancer, unintentional weigh loss, gastrointestinal tract, adults

Brief summary

Patients with cancer often experience appetite loss and weight loss unintentionally. Rapid weight loss negatively impact on physical functioning, quality of life, and overall survival. Patients will be randomly assigned into two groups. An intervention with acupuncture may slow down or stop the progression of cancer-related anorexia and weight loss.

Detailed description

The purpose of this research study is to investigate if acupuncture helps to improve appetite and slow down unintentional weight loss. The participants will be randomly divided into two groups and receive 8 sessions of acupuncture (two groups will receive different acupuncture points) for 8 weeks. During the study period, participants will be asked various questions about appetite, physical functioning, cancer-related symptoms and quality of life to understand changes related to body weight, as well as blood samples. The research team members will collect data regarding changes in appetite, body weight, body composition, and physical functioning.

Interventions

DEVICECachexia Acupuncture-A (Peace Classic Needles® )

Acupuncture-A group will receive acupuncture in a pre-determined set of the acupuncture points.

DEVICEGeneral Acupuncture-B (Peace Classic Needles®)

Acupuncture-B group will receive acupuncture in a pre-determined set of the acupuncture points.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 21 year or older * medical diagnosis of gastrointestinal cancer (for example, gastric, biliary, or colorectal) * experienced weight loss of at least 5% over the last 6 months * ability to communicate in English * ability to follow the research protocol

Exclusion criteria

* plan to have surgical procedures at the time of recruitment * receive radiation therapy alone or in addition to chemotherapy during the study period * undergo surgery during the study or in the months prior to the study * no plan to have chemotherapy after the surgery * any comorbidities that may affect the interpretation of study findings * open burn sites or infected wounds * esophageal cancer or pancreatic cancer * life expectancy of less than 6 months as assessed by attending physician

Design outcomes

Primary

MeasureTime frameDescription
Percentage weight change over 8 weeks between two armsup to 8 weeksWeight will be measured each visit (pounds).

Secondary

MeasureTime frameDescription
Appetite change between two armsup to 8 weeksThree different short survey forms will be used to measure appetite change. Visual analogue scale (0 indicates no appetite and 10 is the best appetite). Simplified Nutritional Appetite Questionnaire score (min-max: 4-20 and the higher the better appetite) Patient Generated Subjective Global Assessment: 0-1, no intervention is needed. 9 or higher score indicates critical intervention.
physical functioningup to 8 weekssurvey form (min-max: 0-100, increment by 10%- 100% indicates full functioning).
body compositionup to 8 weeksSmall, non-invasive device (bioelectrical impedance analysis) like a miniature version of EKG will measure changes in body composition (numeric scale).

Other

MeasureTime frameDescription
biomarkersweeks 1, 4 and 8 (three measurements)Small amounts of blood will be drawn.
symptom experienceup to 8 weeksSurvey format: 13 areas related to the symptom experience and patient's concerns will be assessed (4 points scale; 0 means 'not at all' and 3 means 'very much').
Quality of life between two armsup to 8 weeksSurvey format includes the 27 items (5 points scale: 0 means 'not at all' and 4 means 'very much) .

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026